BRM trade ideas
$BMY hourly chartI am no chartist.. however in the 3 month range, if 50 at close , then 51 calling :)
Bristol-Myers offering an easy 6% $BMY has been struggling the first half of this year, but things are about to get worse. So far this year, each downward slide has been able to hold Sep/Oct13 resistance line converging with the 61.8% fib from the late Aug13 breakout level. Last week that crucial line was severed aided by the downward pressure of a death cross. This lower low break on high selling pressure demonstrates the bears are in control. With all momentum indicators on the weekly in firm landslide mode, I think this daily dead cat bounce into prior support/61.8% fib this week on fading volume is a nice opportunity to pick up some July puts for a profit target of around 44.30, where prior resistance and a breakaway gap last year converge.
Bullish Wolfe Waves + Strong Support on BRISTOLWolfe Waves + Strong Support + Hammer
Nice Risk/Reward
BMY broke down of major support on volume Drug Manufacturer Brystol-Myers was trending up and topped at $57. At $54 it dropped below key moving averages - for me its point to make adjustments.
Recently it has been hovering around 200 EMA and now broke down with conviction on volume above average. The last potential support was at $47.50 but buyers failed to hold it. I think if it will hold below for the next few days then it may continue lower.
Stop for swing traders above $50 (gap down pivot point) makes sence. Target could ve next important level at $42.
Reasonable trade from R/R point of view.
BMY DWe need to get out of this mess, there's several ways to go 1: down outside & flips, 2: Flips and up stay inside and make that support, I'm seeing BMY at 14% up from now ($48.94).
Bristol Meyers Rally Taking a Healthy PauseBMY looks like a great buy to me right now, the stock has been on a tear recently although it has been stair-stepping higher (see Apple) which is very healthful for sustaining its rally, the fundamentals on this stock could not be more impressive with a $7 billion drug in the pipeline plus an already multi-billion dollar drug launched last year, the stock is consolidating at the $50 level holding the most recent gap, the stock is hanging around right at the 50 day with RSI a healthy 45 after digesting the move and the MACD potentially getting ready to reverse
Disclosure: Long Feb 52.5-57.5 call spreads
BMY Long (Option)Rising RSI, MACD, DMI, Accum/Dist.
Price is on runaway in positive direction.
High volume supports enthusiasm.
